VJHemOnc is committed to improving our service to you

VJVirtual | Novel therapies for MPNs

VJHemOnc is committed to improving our service to you

Naveen Pemmaraju

Naveen Pemmaraju, MD, of The University of Texas MD Anderson Cancer, Houston, TX, talks on emerging novel therapies for the treatment of myeloproliferative neoplasms (MPNs), including new classes of agents such as bromodomain inhibitors, Bcl-xL inhibiton, HSP inhibitors, aurora kinase inhibitors and many more. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter